In our hands, however, breast cancer xenografts harboring the insulin-unresponsive, DR-resistant, PIK3CA-activating mutation H1047R remained largely sensitive to the anti-tumoral effects of metformin (29). This evidence concerns the gene INS and breast carcinoma.